Skip to content

Clinical trials

Phase 3 Subarachnoid Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Subarachnoid Hemorrhage Phase: Phase 3 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20074
20092
20101
20111
20121
20161
20183
20191
20201
20211
20222
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9
Completed8
Not yet recruiting3
Unknown status3
Withdrawn1
Recruiting1
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Idorsia Pharmaceuticals Ltd.3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Beijing Tiantan Hospital1
Cambridge University Hospitals NHS Foundation Trust1
Centre Hospitalier St Anne1
Centre Hospitalier Universitaire Vaudois1
Centre Hospitalier Universitaire de Nice1
Changhai Hospital1
Charite University, Berlin, Germany1
Chinese University of Hong Kong1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Subarachnoid Hemorrhage27
Brain Ischemia5
Aneurysm4
Vasospasm, Intracranial4
Hemorrhage2
Intracranial Aneurysm2
Ischemia2
Aneurysm, Ruptured1
Atrial Fibrillation1
Atrial Flutter1

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.